MS was associated with lower serum levels of IgG2 and IgA, increased levels of IgM, decreased proportions of IgG2, and increased proportions of “upstream” IgG subclasses IgG3 and IgG1. The gene discussed is CD79A; the disease is myeloid sarcoma.